Probiodrug to present at European Life Sciences Conferences

Probiodrug Licenses the TBA 2.1 Transgenic Alzheimer’s Disease Mouse Model to QPS Austria Neuropharmacology
Probiodrug to attend and present at US Life Science Conferences